Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raza Alikhan

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Future Oncology (London, England)|November 1, 2019
Suspected cancer symptoms and blood test results in primary care before a diagnosis of lung cancer: a case-control studyLaura McDonald, Robert Carroll, Akash Harish, et al.
Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons|February 8, 2018
Does thromboprophylaxis reduce symptomatic venous thromboembolism in patients with below knee cast treatment for foot and ankle trauma? A systematic review and meta-analysisBen A Hickey, Ultan Watson, Andrew Cleves, et al.
Future Cardiology|May 30, 2019
Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective studySreeram V Ramagopalan, Elaine Stamp, Cormac J Sammon, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 9, 2019
Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink StudyRaza Alikhan, Cinira Lefevre, Ian Menown, et al.
Future Cardiology|April 23, 2021
CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED risk scores and real-world oral anticoagulant prescribing decisions in atrial fibrillationMegan Besford, Thomas P Leahy, Cormac Sammon, et al.
BMJ Open|November 30, 2016
Impact of a dedicated cancer-associated thrombosis service on clinical outcomes: a mixed-methods evaluation of a clinical improvement exerciseSimon Noble, Nikki Pease, Jessica Sui, et al.
Archives of Disease in Childhood|January 21, 2016
Venous thromboembolism occurring during adolescenceTina Biss, Raza Alikhan, Jeanette Payne, et al.
Journal of Comparative Effectiveness Research|February 9, 2019
Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarinSreeram V Ramagopalan, Sophie Graham, Robert Carroll, et al.
Journal of the American College of Emergency Physicians Open|March 14, 2022
Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleedingAlexander T Cohen, Megan Lewis, Augusta Connor, et al.
Emergency Medicine Journal : EMJ|February 26, 2013
The acute management of haemorrhage, surgery and overdose in patients receiving dabigatranRaza Alikhan, Rachel Rayment, David Keeling, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Future Oncology (London, England)|November 1, 2019
Suspected cancer symptoms and blood test results in primary care before a diagnosis of lung cancer: a case-control studyLaura McDonald, Robert Carroll, Akash Harish, et al.
Foot and Ankle Surgery : Official Journal of the European Society of Foot and Ankle Surgeons|February 8, 2018
Does thromboprophylaxis reduce symptomatic venous thromboembolism in patients with below knee cast treatment for foot and ankle trauma? A systematic review and meta-analysisBen A Hickey, Ultan Watson, Andrew Cleves, et al.
Future Cardiology|May 30, 2019
Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective studySreeram V Ramagopalan, Elaine Stamp, Cormac J Sammon, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 9, 2019
Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink StudyRaza Alikhan, Cinira Lefevre, Ian Menown, et al.
Future Cardiology|April 23, 2021
CHA<sub>2</sub>DS<sub>2</sub>-VASc and HAS-BLED risk scores and real-world oral anticoagulant prescribing decisions in atrial fibrillationMegan Besford, Thomas P Leahy, Cormac Sammon, et al.
BMJ Open|November 30, 2016
Impact of a dedicated cancer-associated thrombosis service on clinical outcomes: a mixed-methods evaluation of a clinical improvement exerciseSimon Noble, Nikki Pease, Jessica Sui, et al.
Archives of Disease in Childhood|January 21, 2016
Venous thromboembolism occurring during adolescenceTina Biss, Raza Alikhan, Jeanette Payne, et al.
Journal of Comparative Effectiveness Research|February 9, 2019
Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarinSreeram V Ramagopalan, Sophie Graham, Robert Carroll, et al.
Journal of the American College of Emergency Physicians Open|March 14, 2022
Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleedingAlexander T Cohen, Megan Lewis, Augusta Connor, et al.
Emergency Medicine Journal : EMJ|February 26, 2013
The acute management of haemorrhage, surgery and overdose in patients receiving dabigatranRaza Alikhan, Rachel Rayment, David Keeling, et al.
Pageof 6